Medical Breakthrough: Restoring Fertility Through Tissue Transplantation

A medical team at the University Hospital Brussels and the Free University of Brussels (VUB) has reported a world-first restoration of sperm production in a male patient through the transplantation of testicular tissue frozen during his childhood.

The case involves a man who had been rendered infertile following gonadotoxic treatments received as a child. According to a new case study, the patient was able to produce mature and motile sperm after receiving grafts of his own cryopreserved tissue nearly two decades after the initial preservation.

Childhood Preservation and Adult Infertility

The patient was born with sickle cell anemia, an inherited blood disease. In 2008, when the patient was approximately 10 years old, he and his family consented to the removal of one of his testicles before he began treatment involving donated bone marrow and chemotherapy.

The removed tissue was frozen for future use, a preventative measure taken because chemotherapy and radiation therapies can leave young patients with a substantial risk of infertility in adulthood. For many boys treated for leukemia, sickle cell disease and other illnesses, these therapies can lead to a condition where the ejaculate lacks viable sperm.

In 2022, the man returned to Brussels IVF at VUB with the intention of becoming a father. Medical evaluations at that time confirmed that he had no viable sperm remaining in his remaining testicle.

The Transplantation Procedure

Seeking to restore his fertility, the patient requested the transplantation of the testicular tissue that had been frozen in 2008. As part of a clinical trial in 2025, surgeons reintroduced the thawed tissue into the patient’s body.

The surgical procedure involved the placement of eight tissue grafts in total: four grafts were reintroduced within the patient’s testicle and four were placed within his scrotum.

One year following the surgery, in 2026, the medical team found that some of these grafts were producing mature and motile sperm, marking a significant milestone in the treatment of chemotherapy-induced infertility.

Medical Context: Tissue vs. Sperm Banking

This development is particularly significant for prepubescent boys. While adult men can preserve their fertility by freezing sperm samples before starting cancer treatment, boys who have not yet reached puberty do not produce sperm.

For these pediatric patients, tissue cryopreservation is the only viable option for future biological fatherhood. This process involves freezing immature testicular tissue, which contains the precursor cells necessary for sperm production.

The success of this transplant demonstrates that immature testicular tissue can be stored for nearly 20 years and still remain viable enough to produce mature sperm once reintroduced into an adult environment.

Current Status and Future Implications

The findings were detailed in a case study provided ahead of peer review. While the results for this specific patient are positive, the medical team’s work remains part of a clinical trial to determine the broader applicability and safety of the procedure.

The ability to restore fertility in patients who underwent gonadotoxic treatment in childhood represents a new potential pathway for survivors of pediatric cancer and blood diseases. The medical team at the University Hospital Brussels and the Free University of Brussels (VUB) continues to evaluate the long-term viability of the grafts and the potential for these patients to conceive biological children.